Axsome Therapeutics Stock Forecast
NASDAQ: AXSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:49 PM ET
AXSM analyst consensus
Consensus (22 analysts)
strong_buy
Avg. price target
$284.63+68.35%
- Strong buy 3
- Buy 18
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 22 Wall Street analysts covering Axsome Therapeutics (2026-10-07), 21 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $284.63, with a high estimate of $380.00 and a low estimate of $246.00. The average target implies upside of 68.4% from the current price of $169.07.
The spread between the highest and lowest targets is 54.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for AXSM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 14% |
| Buy | 18 | 82% |
| Hold | 1 | 5% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $246.00 | +45.50% |
| Average target | $284.63 | +68.35% |
| High target | $380.00 | +124.76% |